Anti-angiogenic activity of a small molecule STAT3 inhibitor LLL12.
BACKGROUND: Recent data indicate the Signal Transducer and Activator of Transcription 3 (STAT3) pathway is required for VEGF production and angiogenesis in various types of cancers. STAT3 inhibitors have been shown to reduce tumor microvessel density in tumors but a direct anti-angiogenic activity h...
Main Authors: | Hemant K Bid, Duane Oswald, Chenglong Li, Cheryl A London, Jiayuh Lin, Peter J Houghton |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2012-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3328460?pdf=render |
Similar Items
-
Biologic activity of the novel small molecule STAT3 inhibitor LLL12 against canine osteosarcoma cell lines
by: Couto Jason I, et al.
Published: (2012-12-01) -
A novel small molecule LLL12B inhibits STAT3 signaling and sensitizes ovarian cancer cell to paclitaxel and cisplatin.
by: Ruijie Zhang, et al.
Published: (2021-01-01) -
LLL12B, a Novel Small-Molecule STAT3 Inhibitor, Induces Apoptosis and Suppresses Cell Migration and Tumor Growth in Triple-Negative Breast Cancer Cells
by: Li Pan, et al.
Published: (2022-08-01) -
LLL12B, a small molecule STAT3 inhibitor, induces growth arrest, apoptosis, and enhances cisplatin-mediated cytotoxicity in medulloblastoma cells
by: Xiang Chen, et al.
Published: (2021-03-01) -
CATALYTIC ACTIVITIES OF Al(lll)-, Ga(lll)-, In(lll) AND TI(lll)-PORPHYRIN COMPLEXES
by: Park, Yu Chul, et al.
Published: (1997-04-01)